Neurexin 1 beta/NXRN1b Antibody [CoraFluor™ 1]
Novus Biologicals, part of Bio-Techne | Catalog # AF4524CL1
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Concentration
Product Specifications
Immunogen
Ala47-Thr392
Accession # Q63373
Specificity
Clonality
Host
Isotype
Description
CoraFluor(TM) 1, amine reactive
CoraFluor(TM) 1, thiol reactive
For more information, please see our CoraFluor(TM) TR-FRET technology flyer.
Scientific Data Images for Neurexin 1 beta/NXRN1b Antibody [CoraFluor™ 1]
Product Feature: CoraFluor Probes for TR-FRET
CoraFluor™ 1, amine reactive (Catalog:7920) and CoraFluor™ 2, amine reactive (Catalog # 7950) are terbium-based probes that have been developed for use as TR-FRET donors. They emit wavelengths compatible with commonly used fluorescent acceptor dyes such as BODIPY® (or BDY) and Janelia Fluor® dyes, FITC (Catalog # 5440), TMR and Cyanine 5 (Catalog # 5436). CoraFluor™ fluorescence is brighter and more stable in biological media than existing TR-FRET donors, leading to enhanced sensitivity and improved data generation. CoraFluor™ 1 exhibits excitation upon exposure to a 337 nm UV laser.Applications for Neurexin 1 beta/NXRN1b Antibody [CoraFluor™ 1]
Western Blot
Formulation, Preparation, and Storage
Purification
Formulation
Preservative
Concentration
Shipping
Stability & Storage
Background: Neurexin 1 beta/NXRN1b
The alpha and beta forms of Neurexins 1 - 3 are transmembrane neuronal glycoproteins which are transcribed from each of the three NRXN genes from alternate promoters. The interaction of presynaptic Neurexins with postsynaptic Neuroligins is important for synaptic development and is restricted to particular combinations of splice forms of each binding partner.
Alternate Names
Gene Symbol
Additional Neurexin 1 beta/NXRN1b Products
Product Documents for Neurexin 1 beta/NXRN1b Antibody [CoraFluor™ 1]
Product Specific Notices for Neurexin 1 beta/NXRN1b Antibody [CoraFluor™ 1]
CoraFluor (TM) is a trademark of Bio-Techne Corp. Sold for research purposes only under agreement from Massachusetts General Hospital. US patent 2022/0025254
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.